Understanding side effects and quality of life for diverse patients using immune therapies for cancer.
Symptomatic Toxicities & Quality of Life among Diverse Individuals Receiving Immune Checkpoint Inhibitors for Metastatic Cancer.
This study is looking at how different people with advanced cancer feel while getting immune checkpoint inhibitors, focusing on their side effects and quality of life, to help improve support and care for patients like you.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11040016 on NIH RePORTER |
What this research studies
This research investigates the side effects and overall quality of life experienced by patients from diverse backgrounds who are receiving immune checkpoint inhibitors for metastatic cancer. It aims to gather patient-reported outcomes to better understand the range of mild to severe toxicities associated with these treatments. By focusing on a well-characterized group of racially, ethnically, and socioeconomically diverse individuals, the study seeks to identify predictors of these toxicities and their impact on patients' lives. The findings could help improve care delivery and support for patients undergoing this type of cancer therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with metastatic cancer who are being treated with immune checkpoint inhibitors.
Not a fit: Patients not receiving immune checkpoint inhibitors or those with early-stage cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management of side effects and enhanced quality of life for cancer patients receiving immune therapies.
How similar studies have performed: Previous research has shown that understanding patient-reported outcomes can significantly enhance treatment strategies and patient care in oncology, indicating a promising approach in this area.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Moreno, Patricia Ingrid — University of Miami School of Medicine
- Study coordinator: Moreno, Patricia Ingrid
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.